Laser or timolol gel for fast-growing birthmark in infants
Part of Cancer clinical trials.
This study compares three approaches—pulsed-dye laser, timolol (a medicated skin solution), or watch-and-wait—to see which works best to slow the growth of a hemangioma birthmark in young babies. It may help find a treatment that shrinks or controls the birthmark as early as possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby is under 3 months old
- Baby has one or more superficial hemangiomas that are starting to grow quickly
- The birthmark was absent or barely visible at birth, then became more noticeable within the first month
- Parent/guardian agrees to join, sign consent, and follow all visits and at-home care
- Parent/guardian agrees not to use other birthmark medicines (skin or oral) unless the study doctor prescribes them
- Baby has no serious health problems that would make participation difficult
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at babies with a common birthmark called infantile hemangioma (made of blood vessels) to help doctors decide the best treatment or whether monitoring is enough. It involves a first evaluation and follow-up, but no new drugs or procedures are tested.
This study compares two treatments for a common infant skin birthmark called hemangioma. One uses a special diode laser and the other uses a medicine called bleomycin, both aimed at shrinking or improving the birthmark.
This pilot study tests a gel called sirolimus to see if it can safely shrink or improve raised, dark birthmarks (epidermal nevi) in people 6 and older. The gel is applied directly to the birthmark, and the study will check how well it works and if it causes any side effects.
This study compares two ways of stopping propranolol in children with infantile hemangioma (a type of birthmark): stopping suddenly versus slowly reducing the dose. It aims to find out which method is safer and better at preventing the birthmark from growing back.
This trial tests a cream containing simvastatin, a cholesterol medicine, applied to infantile hemangiomas (strawberry birthmarks) in babies aged 3-6 months. It may help shrink the birthmark without needing stronger treatments.
This trial tests a laser treatment for vascular birthmarks (like port-wine stains). It might help if your birthmark is on an area of your body that is not the center of your face and you have light to medium skin.
Hear when a new Hemangioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.